Literature DB >> 14569093

Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.

Marcin Adamczak1, Marie-Luise Gross, Jan Krtil, Andreas Koch, Karin Tyralla, Kerstin Amann, Eberhard Ritz.   

Abstract

Interventions to block the renin-angiotensin system (RAS) halt the progression of renal lesions in renal damage models. It has recently also been reported that established glomerulosclerosis can be reversed by pharmacologic blockade of the RAS. It was the aim of this study to confirm that high doses of angiotensin-converting enzyme (ACE) inhibitors reverse established glomerulosclerosis and to extend the findings by providing quantitative information on glomerular geometry, podocytes and other glomerular cells, renal vessels and tubulointerstitial tissue. Male Sprague Dawley rats were subjected to subtotal surgical renal ablation (SNX) (n = 27) or sham operation (n = 31) and fed using a pair-feeding protocol. Eight weeks after surgery, rats were either sacrificed or allocated to two arms: enalapril treatment (48 mg/kg body wt per day administered in the drinking fluid for 4 wk) or no treatment. Renal morphology was evaluated after 8 or 12 wk, respectively, by stereology in tissue fixed by pressure-controlled perfusion. Both systolic BP and albumin excretion rate were significantly higher in SNX compared with sham-operated controls. They were significantly reduced in SNX after delayed enalapril treatment. The glomerulosclerosis (GSI), tubulointerstitial (TII), and vascular (VI) damage indices were significantly higher in all SNX groups than in sham-operated controls. At the end of the experiment (12 wk after SNX) GSI, TII, and VI were significantly lower in SNX with delayed enalapril treatment (0.77 +/- 0.18, 0.63 +/- 0.19 and 0.43 +/- 0.16, respectively) compared with untreated SNX (1.64 +/- 0.14, 1.16 +/- 0.34 and 0.67 +/- 0.29, respectively). GSI, TII, and VI were also significantly lower in SNX with delayed enalapril treatment compared with SNX sacrificed without treatment 8 wk after SNX. The same was true for glomerular volume. The number of podocytes was not affected by SNX, but podocyte volume was increased. Both indices remained unaffected by treatment. The numbers of cells within the mesangium and endothelial cells per glomerulus were significantly lower in SNX after delayed enalapril treatment compared with untreated SNX. These results strongly suggest regression of preexisting lesions, i.e., glomerular, tubular, and vascular remodeling as well as reversal of glomerular hypertrophy by ACE inhibitor treatment. The study confirms that high-dose ACE inhibitor treatment causes partial reversal of glomerular as well as interstitial lesions in subtotally nephrectomized rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14569093     DOI: 10.1097/01.asn.0000095248.91994.d3

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  47 in total

1.  Telmisartan protects 5/6 Nx rats against renal injury by enhancing nNOS-derived NO generation via regulation of PPARγ signaling.

Authors:  Rong Zou; Yong He; Yue-Qiang Li; Ming Han; Zu-Fu Ma; Xiao-Cheng Liu; Rui Zeng; Jv-Fang Shao; Yan-Chao Guo; Xiao-Yu He; Ping Yang; Gang Xu; Cong-Yi Wang; Ying Yao
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

2.  Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy.

Authors:  Putri A Agustian; Mario Schiffer; Wilfried Gwinner; Irini Schäfer; Katharina Theophile; Friedrich Modde; Clemens L Bockmeyer; Jana Traeder; Ulrich Lehmann; Anika Grosshennig; Hans H Kreipe; Verena Bröcker; Jan U Becker
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 3.  Compelling drug indications in diabetic and nondiabetic nephropathy.

Authors:  Eberhard Ritz; Ralf Dikow; Martin Zeier
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

4.  Animal models of regression/progression of kidney disease.

Authors:  Beom Jin Lim; Hai-Chun Yang; Agnes B Fogo
Journal:  Drug Discov Today Dis Models       Date:  2014

Review 5.  Renal failure and ACE inhibition: how much is too much?

Authors:  M-L Gross; M Adamczak; E Ritz
Journal:  Z Kardiol       Date:  2005-02

6.  Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats.

Authors:  Catherine Meyer-Schwesinger; Claudia Lange; Verena Bröcker; Putri Andina Agustian; Putri Andina Agustian; Ulrich Lehmann; Annette Raabe; Martina Brinkmeyer; Eiji Kobayashi; Mario Schiffer; Guntram Büsche; Hans H Kreipe; Friedrich Thaiss; Jan U Becker
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 7.  Modulation of glomerulosclerosis.

Authors:  Li-Jun Ma; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

8.  Kidney regeneration in mammals.

Authors:  Hai-Chun Yang; Shao-Jun Liu; Agnes B Fogo
Journal:  Nephron Exp Nephrol       Date:  2014-05-19

9.  Towards adulthood with a solitary kidney.

Authors:  Pierre Cochat; Olivia Febvey; Justine Bacchetta; Etienne Bérard; Natalia Cabrera; Laurence Dubourg
Journal:  Pediatr Nephrol       Date:  2018-10-01       Impact factor: 3.714

10.  Improvement in eGFR in patients with chronic kidney disease attending a nephrology clinic.

Authors:  Hulya Taskapan; Paul Tam; Victoria Au; Stephen Chow; Jason Fung; Gordon Nagai; Janet Roscoe; Paul Ng; Tabo Sikaneta; Robert Ting; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2008-04-02       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.